Clinical Trial Update: Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing lactulose, L-ornithine L-aspartate, and rifaximin against placebo to prevent hepatic encephalopathy in patients with variceal b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy

Drugs mentioned

• L-ornithine-L-aspartate (L-ornithine-L-aspartate)
• LACTULOSE (Lactulose)
• Rifaximin (rifaximin)

Snippet

Sponsor: Hospital General de Mexico | Conditions: Hepatic Encephalopathy | Phase 4 | Status: COMPLETED